New specific molecular targets for radio-chemotherapy of rectal cancer

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Locally advanced rectal cancer treatment often involves preoperative radio-chemotherapy (RCT).
• The precise molecular mechanisms underlying tumor response to RCT remain largely unknown.
• Understanding gene expression changes is crucial for optimizing treatment strategies.

Purpose of the Study:

• To investigate the impact of RCT on gene expression profiles in rectal tumor and adjacent normal tissues.
• To identify specific genes and pathways affected by preoperative radio-chemotherapy in rectal adenocarcinoma.
• To elucidate the molecular basis of tumor response to neoadjuvant therapy.

Main Methods:

• Whole genome-microarray based gene expression analysis of tissue samples from 21 rectal adenocarcinoma patients.
• Utilized a factorial experimental design to isolate the effects of RCT on tumor tissue.
• Applied Gene Set Enrichment Analysis (GSEA) to identify enriched biological pathways.

Main Results:

• Identified 1327 differentially expressed genes in tumor tissue post-RCT (p<0.05).
• Observed significant enrichment in gene sets related to cell adhesion and leukocyte transendothelial migration.
• Detected profound alterations in cell adhesion molecule expression within rectal tumor tissue.

Conclusions:

• RCT induces significant changes in gene expression in rectal tumors, affecting key cellular processes.
• Altered cell adhesion molecule expression may have dual implications for metastatic potential and tumor invasiveness.
• Further research is warranted to clarify the clinical significance of these gene expression changes for patient outcomes.